Stockscreener 앱 받기
31.34
1.66%
-0.53
전일 마감가:
$31.87
열려 있는:
$31.97
하루 거래량:
1.86M
Relative Volume:
0.89
시가총액:
$3.98B
수익:
$1.12B
순이익/손실:
$5.00M
주가수익비율:
3,134.00
EPS:
0.01
순현금흐름:
$-383.00M
1주 성능:
+6.71%
1개월 성능:
+32.12%
6개월 성능:
+173.00%
1년 성능:
+189.65%
1일 변동 폭
$30.40
$31.97
1주일 범위
$29.55
$32.42
52주 변동 폭
$7.62
$32.42
Indivior Plc Stock (INDV) Company Profile
명칭
Indivior Plc
전화
804-379-1090
주소
234 BATH ROAD, SLOUGH, BERKSHIRE
INDV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
31.34 | 3.98B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
120.24 | 52.69B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 43.09B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.90B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
23.97 | 28.06B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.91 | 19.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | H.C. Wainwright | Buy |
| 2025-07-22 | 재개 | Jefferies | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-07-23 | 개시 | Piper Sandler | Overweight |
| 2024-04-03 | 개시 | Craig Hallum | Buy |
| 2023-07-13 | 개시 | Northland Capital | Outperform |
모두보기
Indivior Plc 주식(INDV)의 최신 뉴스
Settlement with pharmaceutical company recovers $3.1M for N.J. Medicaid - Essex News Daily
Does Indivior PLC show high probability of rebound2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Is Indivior PLC stock bottoming outJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Is Indivior PLC (2IVB) stock attractive post correction2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Published on: 2025-11-06 02:52:41 - newser.com
Intraday pattern recognizer results for Indivior PLCWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Will Indivior PLC stock deliver long term returnsRisk Management & Low Risk High Win Rate Picks - newser.com
Real time scanner hits for Indivior PLC explained2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Can Indivior PLC stock reach $100 price targetTrade Ideas & Fast Moving Trade Plans - newser.com
Using Python tools to backtest Indivior PLC strategiesWeekly Trading Summary & Real-Time Volume Analysis - newser.com
Will Indivior PLC (2IVB) stock benefit from sector leadershipWeekly Trading Summary & Precise Swing Trade Entry Alerts - fcp.pa.gov.br
Using RSI to spot recovery in Indivior PLCWeekly Stock Report & Risk Managed Investment Strategies - newser.com
How Indivior PLC stock trades during market volatilityWeekly Investment Report & AI Based Buy and Sell Signals - newser.com
Why analysts upgrade Indivior PLC stockEarnings Risk Report & Reliable Volume Spike Alerts - newser.com
Here's Why Indivior Stock Soared 15% Today - MSN
Applying chart zones and confluence areas to Indivior PLCJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - newser.com
Can Indivior PLC stock beat market expectations this quarterJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Is Indivior PLC stock attractive for income investorsPortfolio Value Summary & Accurate Buy Signal Alerts - newser.com
Indivior (INDV) Is Up 25.9% After Strong Q3 Results and Raised Revenue Guidance Has The Bull Case Changed? - simplywall.st
INDV Crosses Above Average Analyst Target - Nasdaq
EBIT per share of Indivior PLC – LS:A3DWFC - TradingView
Indivior to pursue a change in domicile from the U.K. to the U.S - MSN
One-Year Outcomes of Real-World RECOVERâ„¢ Study Published in Jo - GuruFocus
Leading vs lagging indicators on Indivior PLC performance2025 Institutional Moves & Long-Term Safe Investment Ideas - newser.com
Monthly buprenorphine treatment shows lower relapse rates in OUD patients - Investing.com
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine - PR Newswire
Indivior PLC’s Optimistic Earnings Call Highlights Growth - MSN
Will Indivior PLC stock benefit from infrastructure spending2025 Stock Rankings & Scalable Portfolio Growth Ideas - newser.com
Indivior Plc (INDV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
0.10%
자본화:
|
볼륨(24시간):